MY8600678A - Substituted pyrimidines their synthesis and compositions containing them their use in medicine and intermediates for making them - Google Patents

Substituted pyrimidines their synthesis and compositions containing them their use in medicine and intermediates for making them

Info

Publication number
MY8600678A
MY8600678A MY678/86A MY8600678A MY8600678A MY 8600678 A MY8600678 A MY 8600678A MY 678/86 A MY678/86 A MY 678/86A MY 8600678 A MY8600678 A MY 8600678A MY 8600678 A MY8600678 A MY 8600678A
Authority
MY
Malaysia
Prior art keywords
intermediates
medicine
synthesis
making
compositions containing
Prior art date
Application number
MY678/86A
Other languages
English (en)
Inventor
Daluge Susan Mary
Skenezny Paul Marcel
Original Assignee
Daluge Susan Mary
Skenezny Paul Marcel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daluge Susan Mary, Skenezny Paul Marcel filed Critical Daluge Susan Mary
Publication of MY8600678A publication Critical patent/MY8600678A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C07D239/49—Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/40—Nitrogen atoms attached in position 8
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/64—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with oxygen atoms directly attached in position 8

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
MY678/86A 1980-11-11 1986-12-30 Substituted pyrimidines their synthesis and compositions containing them their use in medicine and intermediates for making them MY8600678A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8036135 1980-11-11

Publications (1)

Publication Number Publication Date
MY8600678A true MY8600678A (en) 1986-12-31

Family

ID=10517217

Family Applications (1)

Application Number Title Priority Date Filing Date
MY678/86A MY8600678A (en) 1980-11-11 1986-12-30 Substituted pyrimidines their synthesis and compositions containing them their use in medicine and intermediates for making them

Country Status (35)

Country Link
US (4) US4438267A (pt)
EP (1) EP0051879B1 (pt)
JP (1) JPS57114581A (pt)
KR (1) KR880001736B1 (pt)
AR (1) AR245447A1 (pt)
AU (1) AU549449B2 (pt)
CA (1) CA1186310A (pt)
CS (1) CS273153B2 (pt)
CY (1) CY1419A (pt)
DD (1) DD201896A5 (pt)
DE (1) DE3173752D1 (pt)
DK (1) DK172884B1 (pt)
EG (1) EG16107A (pt)
ES (5) ES8307759A1 (pt)
FI (1) FI76333C (pt)
GB (1) GB2087881B (pt)
GR (1) GR81317B (pt)
HK (1) HK23388A (pt)
HU (1) HU188762B (pt)
IE (1) IE52128B1 (pt)
IL (1) IL64256A (pt)
IT (1) IT1210589B (pt)
MC (1) MC1418A1 (pt)
MY (1) MY8600678A (pt)
NO (2) NO160137C (pt)
NZ (1) NZ198932A (pt)
PH (2) PH22654A (pt)
PL (4) PL139827B1 (pt)
PT (1) PT73960B (pt)
RU (1) RU1819264C (pt)
SG (1) SG62686G (pt)
SU (4) SU1424732A3 (pt)
YU (5) YU42444B (pt)
ZA (1) ZA817780B (pt)
ZM (1) ZM9481A1 (pt)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4438267A (en) * 1980-11-11 1984-03-20 Daluge Susan M Monoheteroring compounds and their use
DK190983A (da) * 1982-05-01 1983-11-02 Wellcome Found 2,4-diamino-5-(substituerede)pyrimidiner, fremgangsmaade til deres fremstilling og mellemprodukter derfor
ZA833067B (en) * 1982-05-01 1984-12-24 Wellcome Found Antibacterial compounds
US4590271A (en) * 1982-05-01 1986-05-20 Burroughs Wellcome Co. 2,4-diamino-5-(substituted)pyrimidines, useful as antimicrobials
US4587341A (en) * 1982-05-07 1986-05-06 Burroughs Wellcome Co. 2,4-diamino-5-(1,2,3,4-tetrahydro-(substituted or unsubstituted)-6-quinolylmethyl)pyrimidines, useful as antimicrobials
CA1244028A (en) * 1983-04-14 1988-11-01 Hans Maag Pyrimidine derivatives
GB8603964D0 (en) * 1986-02-18 1986-03-26 Cooper Animal Health Ltd Compositions
GB8603962D0 (en) * 1986-02-18 1986-03-26 Wellcome Found Chemical compositions
LU86703A1 (fr) * 1986-12-08 1988-07-14 Oreal Composition cosmetique photostable contenant un filtre uv-a et un filtre uv-b,son utilisation pour la protection de la peau contre les rayons uv et procede de stabilisation du filtre uv-a par le filtre uv-b
FI895821A0 (fi) * 1988-12-07 1989-12-05 Wellcome Found Farmaceutiskt aktiva cns foereningar.
GB8903978D0 (en) * 1989-02-22 1989-04-05 Coopers Animal Health Chemical compositions
GB9000241D0 (en) * 1990-01-05 1990-03-07 Coopers Animal Health Pharmaceutical use
RU95113597A (ru) * 1992-12-02 1997-06-10 ФМК Корпорейшн (US) Инсектицидная композиция, способы борьбы с насекомыми
US5707996A (en) * 1995-11-06 1998-01-13 Macleod Pharmaceuticals, Inc. Pharmaceutical solution and methods for preparation thereof
EP0866791B1 (en) * 1995-12-04 2002-01-30 Arpida AG, Diaminopyrimidines, pharmaceutical compositions containing them and their use as antibacterial
WO2002010156A1 (en) * 2000-07-29 2002-02-07 Arpida Ag Benzofuran derivatives and their use as antibacterial agents
CA2452368A1 (en) * 2001-06-29 2003-01-09 Ab Science New potent, selective and non toxic c-kit inhibitors
ATE330608T1 (de) * 2001-06-29 2006-07-15 Ab Science Die verwendung von n-phenyl-2-pyrimidine-amine derivaten zur behandlung von entzündlichen erkrankungen
ATE343415T1 (de) 2001-06-29 2006-11-15 Ab Science Die verwendung von c-kit hemmer zur behandlung von entzündlichen darmerkrankungen
EP1401413B1 (en) * 2001-06-29 2006-11-22 AB Science Use of tyrosine kinase inhibitions for treating allergic diseases
EP1461032B1 (en) * 2001-09-20 2008-07-16 AB Science Use of c-kit inhibitors for promoting hair growth
DE60228278D1 (de) * 2001-09-20 2008-09-25 Ab Science Die verwendung von potenten, selektiven und nontoxischen c-kithemmern zur behandlung von interstitieller blasenentzündung
CA2461181A1 (en) * 2001-09-20 2003-05-01 Ab Science Use of potent, selective and non-toxic c-kit inhibitors for treating bacterial infections
DE602004027384D1 (de) * 2003-07-11 2010-07-08 Arpida Ag Benzofuranderivate und deren verwendung bei der behandlung von mikrobiellen infektionen
CZ2007537A3 (cs) * 2005-02-18 2008-02-20 Arpida Ag Nové zpusoby výroby benzofuranové slouceniny
CN101253159B (zh) * 2005-09-01 2011-12-07 弗·哈夫曼-拉罗切有限公司 作为p2x3和p2x2/3调节剂的二氨基嘧啶类化合物
US20100029689A1 (en) * 2008-07-02 2010-02-04 Memory Pharmaceuticals Corporation Phosphodiesterase 4 inhibitors
CA2778931A1 (en) * 2009-06-12 2010-12-16 Marianne Allard Guanine riboswitch binding compounds and their use as antibiotics
CN102649786B (zh) * 2011-02-28 2014-08-27 郑州福源动物药业有限公司 一种2，4-二氨基-5-(8-二甲氨基-7-甲基-5-喹啉基甲基)-2，4-(1h，3h)嘧啶的制备方法
CN103755684B (zh) * 2014-02-10 2015-09-09 青岛蔚蓝生物股份有限公司 一种巴喹普林的制备方法
CN113924293B (zh) * 2019-06-06 2024-07-09 北京泰德制药股份有限公司 P2x3和/或p2x2/3受体拮抗剂、包含其的药物组合物及其用途
CN110818694B (zh) * 2019-11-18 2023-04-21 上海医药工业研究院有限公司 艾拉普林中间体及其应用
US20240226100A1 (en) * 2021-04-09 2024-07-11 The Trustees Of The University Of Pennsylvania Control of protein expression with tmp-protac compounds

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3049544A (en) * 1962-08-14 Method for the preparation of
DE1303727B (de) 1959-09-03 1976-02-05 Ausscheidung aus: 14 45 176 The Wellcome Foundation Ltd., London Alpha-Arylidensubstituierte Propioni-Irile
US3956327A (en) * 1969-03-06 1976-05-11 Burroughs Wellcome Co. Method of preparing 2,4-diamino-5-benzyl pyrimidines
BE792096A (fr) * 1971-12-01 1973-05-30 Hoffmann La Roche Nouvelles benzylpyrimidines
GB1468374A (en) 1974-03-06 1977-03-23 Wellcome Found Process for preparing a pyrimidine derivative
US4039543A (en) 1974-12-24 1977-08-02 Hoffmann-La Roche Inc. Benzylpyrimidines
GB1582245A (en) * 1976-06-09 1981-01-07 Wellcome Found Benzyl cyanoacetal derivatives and their conversion to pyrimidine derivatives
DE2730467A1 (de) * 1977-07-06 1979-01-18 Basf Ag Benzylpyrimidine, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
US4258045A (en) * 1979-11-30 1981-03-24 Merck & Co., Inc. Inhibitor of dihydrofolate reductase
US4438267A (en) * 1980-11-11 1984-03-20 Daluge Susan M Monoheteroring compounds and their use

Also Published As

Publication number Publication date
FI813546L (fi) 1982-05-12
SU1318148A3 (ru) 1987-06-15
NO160137C (no) 1989-03-15
GB2087881B (en) 1985-05-15
ES8405379A1 (es) 1984-06-01
IL64256A (en) 1988-01-31
US4587342A (en) 1986-05-06
YU46697B (sh) 1994-04-05
NZ198932A (en) 1985-05-31
ES521201A0 (es) 1984-06-01
NO160137B (no) 1988-12-05
YU198183A (en) 1984-04-30
YU198383A (en) 1984-04-30
US4438267A (en) 1984-03-20
PL239279A1 (en) 1983-08-01
EP0051879A2 (en) 1982-05-19
CS273153B2 (en) 1991-03-12
YU198283A (en) 1984-04-30
PL233754A1 (en) 1983-08-01
PL139523B1 (en) 1987-01-31
PH25053A (en) 1991-01-28
FI76333C (fi) 1988-10-10
HU188762B (en) 1986-05-28
ES8405377A1 (es) 1984-06-01
AR245447A1 (es) 1994-01-31
JPS57114581A (en) 1982-07-16
YU266381A (en) 1984-04-30
PH22654A (en) 1988-10-28
ES506969A0 (es) 1983-07-01
GR81317B (pt) 1984-12-11
SU1306473A3 (ru) 1987-04-23
PL239280A1 (en) 1983-08-01
KR830007628A (ko) 1983-11-04
PL139827B1 (en) 1987-02-28
IT8149676A0 (it) 1981-11-10
ES8307759A1 (es) 1983-07-01
ZM9481A1 (en) 1983-11-21
IL64256A0 (en) 1982-02-28
AU549449B2 (en) 1986-01-30
JPH0474351B2 (pt) 1992-11-26
PL239278A1 (en) 1983-08-01
SG62686G (en) 1987-03-27
PL139427B1 (en) 1987-01-31
AU7733481A (en) 1982-05-20
CA1186310A (en) 1985-04-30
MC1418A1 (fr) 1982-10-18
ES521203A0 (es) 1984-06-01
PL139828B1 (en) 1987-02-28
EP0051879B1 (en) 1986-02-05
YU43551B (en) 1989-08-31
NO813804L (no) 1982-05-12
US4603136A (en) 1986-07-29
DE3173752D1 (en) 1986-03-20
IE52128B1 (en) 1987-06-24
DK172884B1 (da) 1999-09-06
ES8405380A1 (es) 1984-06-01
IT1210589B (it) 1989-09-14
PT73960B (en) 1983-11-23
KR880001736B1 (ko) 1988-09-10
ES521204A0 (es) 1984-06-01
IE812631L (en) 1982-05-11
RU1819264C (ru) 1993-05-30
YU144288A (en) 1990-04-30
CY1419A (en) 1988-04-22
FI76333B (fi) 1988-06-30
US4761475A (en) 1988-08-02
CS825781A2 (en) 1990-07-12
PT73960A (en) 1981-12-01
DK496681A (da) 1982-05-12
DD201896A5 (de) 1983-08-17
SU1535379A3 (ru) 1990-01-07
ZA817780B (en) 1983-06-29
GB2087881A (en) 1982-06-03
ES8405378A1 (es) 1984-06-01
YU42444B (en) 1988-08-31
EG16107A (en) 1987-10-30
EP0051879A3 (en) 1982-08-04
SU1424732A3 (ru) 1988-09-15
HK23388A (en) 1988-04-08
NO1994029I1 (no) 1994-12-29
ES521202A0 (es) 1984-06-01

Similar Documents

Publication Publication Date Title
MY8600678A (en) Substituted pyrimidines their synthesis and compositions containing them their use in medicine and intermediates for making them
EG15683A (en) New composition of matter
IL64504A (en) Aminoalkoxyphenyl substituted quinazolinones and pyridopyrimidinones,their preparation and pharmaceutical compositions containing them
JPS56164200A (en) Biological synthesis of beta-endolphin
IL58076A0 (en) Spiro-oxazolidindiones pharmaceutical compositions containing them and intermediates useful in their preparation
DE3174913D1 (en) Homobrassinolide and its synthesis
GB2089816B (en) Tri- tetra- and penta-peptides their preparation and compositions containing them
DE3168067D1 (en) 2-guanidino-4-heteroarylthiazoles and pharmaceutical compositions containing them
GB2088373B (en) Dibenzazepine derivatives and pharmaceutical compositions containing them
DE3165444D1 (en) C-beta-d-xylopyranoside series compounds and pharmaceutical compositions containing them
NZ196774A (en) Dibenzooxepines pharmaceutical compositions containing them and intermediates for their preparation
DE3068706D1 (en) Novel benzodiazepine compounds, their preparation, intermediates employed in their preparation, and pharmaceutical compositions containing them
IL64054A (en) Imidazolylpyridines and pharmaceutical compositions containing them
JPS56118010A (en) Cosmetic composition
GB2051794B (en) Hydroxyamino-eburnane derivatives their preparation and use pharmalceutical compositions containing them and intermediates therefor
PT81488A (en) Polycyclic biocidal compounds their synthesis and intermediates therefor formulations containing them and their use in medicine
NZ196640A (en) Pyrimidone derivatives; pharmaceutical compositions
DE3165337D1 (en) Bicyclooctane compounds, their production, compositions containing them and their pharmaceutical use
JPS5711983A (en) Novel benzologue and synthesis thereof
GB2067560B (en) 1-phenyl-4-morpholino-1-buten-3-ol derivatives their preparation and compositions containing them
MY8500811A (en) Sulfonamide derivatives compositions containing them and their production and use
KE3650A (en) Substituted pyrimidines,their synthesis and compositions containing them,their use in medicine and intermediates for making them
IL62146A (en) Guanylamidines and pharmaceutical compositions containing them
GB2068960B (en) Benzylidene derivatives their preparation and compositions containing them
JPS56104884A (en) Substituted benzopyranotriazoles* their manufacture and medicinal composition containing them